Jefferies Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $40
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsInitiationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Jefferies analyst Faisal Khurshid initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $40.
Jefferies analyst Faisal Khurshid initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $40.
